Animal Aids Market Research, 2033
The global animal aids market size was valued at $0.9 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033. The animal aids market has experienced growth due to several factors such as increasing pet ownership, rising awareness of animal health and wellness, and advancements in veterinary medicine and technology. Additionally, the growing prevalence of animal diseases and the expansion of livestock farming contribute to the market's growth.
Market Introduction and Definition
Animal Aid is an organization dedicated to the welfare and protection of animals, committed to alleviating the suffering of all creatures, whether domestic, farmed, or wild. Founded on principles of compassion and ethical treatment, Animal Aid operates through various initiatives including rescue operations, rehabilitation programs, advocacy for animal rights, and educational outreach. The organization actively works to promote humane treatment and prevent cruelty through legal reforms and public awareness campaigns. By providing medical care, shelter, and adoption services for abandoned and mistreated animals, Animal Aid seeks to create a world where animals are treated with respect and kindness. Their efforts extend globally, addressing issues such as factory farming, animal testing, and wildlife conservation, aiming to foster a more compassionate society that recognizes the intrinsic value of all animal life.
Key Takeaways
- The animal aids industry study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Million) for the projected period 2024-2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major animal aids industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.
Key Market Dynamics
The Animal aids market size is driven by several factors, including the increasing incidence of Legionnaires' disease and stringent regulations for water safety and quality. For instance, the rising awareness about the health risks associated with Legionella bacteria has prompted public health agencies and regulatory bodies to enforce strict guidelines for testing and monitoring water systems in various settings such as hospitals, hotels, and industrial facilities. This heightened vigilance has significantly boosted the demand for effective Legionella testing solutions. In addition, advancements in testing technologies, such as the development of rapid and more accurate testing kits, have further fueled market growth by offering reliable and timely results, enabling swift corrective actions to prevent outbreaks.
However, the animal aids market growth faces certain restraints that could impede its growth. One major challenge is the high cost of advanced animal aids, which can be prohibitive for smaller facilities or those in developing regions with limited budgets. In addition, the need for specialized training to operate these kits effectively and interpret the results accurately can be a barrier, particularly in areas with a shortage of skilled personnel. This leads to underutilization of available testing technologies and inadequate monitoring of water systems, thereby compromising the effectiveness of preventive measures.
Despite these challenges, it also presents significant animal aids market opportunity. The growing trend towards smart building technologies and the integration of IoT (Internet of Things) in water management systems offer promising prospects for the Animal aids market. For example, the implementation of automated water monitoring systems equipped with IoT sensors can facilitate real-time detection of Legionella, allowing for immediate response and mitigation. Furthermore, the increasing focus on sustainable water management practices and the expansion of healthcare infrastructure in emerging economies are likely to create new avenues for market expansion. These regions, recognizing the importance of maintaining water safety, are expected to invest more in advanced testing solutions, thereby driving the growth during animal aids market forecast.
Market Segmentation
The animal aids market is segmented into product type, animal type, end user, and region. On the basis of product type, the market is divided into medicinal products, nutritional supplements, diagnostic products, surgical equipment, and wound care products. By animal type, the market is classified into companion animals, livestock animal, and wildlife animal. By end user, the market is categorized into veterinary clinics & hospitals, animal shelters & rescue centers, farms & ranches, and pet owners. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
The North America held largest animal aids market share due to high rate of pet ownership, coupled with the growing humanization of pets, leading to increased spending on their health and wellness. Advancements in veterinary medicine and technology, such as telemedicine and digital health solutions, further boost the market. In addition, the prevalence of animal diseases and the expansion of livestock farming demand effective health management solutions. Strong awareness and proactive measures for animal health among pet owners and farmers also contribute significantly to market growth in this region.
- In June 2023, the U.S. Department of Agriculture (USDA) announced that it is implementing a multi-step effort aimed at strengthening the substantiation of animal-raising claims. This action builds on the significant work USDA has already undertaken to protect consumers from false and misleading labels and to implement President Biden’s Executive Order on Promoting Competition in the American economy.
- In February 2024, Reliance Industries and Reliance Foundation launched of Vantara (Star of the Forest) programme, an umbrella initiative to focus on rescue, treatment, care and rehabilitation of injured, abused and threatened animals, both in India and abroad. Spread over 3, 000 acres within the Green Belt of Reliance’s Jamnagar (India) Refinery Complex, Vantara aims to be one of the leading contributors to conservation efforts globally.
Industry Trends
- In April 2024, the Governor of New York announced nearly $3.8 million has been awarded to 10 animal care organizations across the state through the New York State Companion Animal Capital Fund, which is in its sixth round. The funding is expected to support construction, renovation, and expansion projects that are projected to enhance animal care and health and help ensure adoptions for New York's dogs and cats.
- In April 2023, India showcases two new initiatives – the Animal Pandemic Preparedness Initiative (APPI) and the World Bank-funded Animal Health System Support for One Health (AHSSOH) , at a side event of the G20 Health Working Group meeting scheduled to be held in Goa.
Patent Analysis, By Country, 2015-2024
U.S. witnessed the highest number of patent approvals and applications, due to favorable government policies, new technological advancement ad new product launches in the country. PCT 15.7% of the total number of patents, followed by China at 15.0% and European Patent Office at 11.5%.
Competitive Landscape
The major animal aids market share holder players operating in the animal aids market include Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health, Bayer Animal Health, Ceva Santé Animale, Virbac, Vetoquinol, Dechra Pharmaceuticals, Phibro Animal Health Corporation. Other players in animal aids market includes IDEXX Laboratories, Neogen Corporation, Heska Corporation and so on.
Recent Key Strategies and Developments
- In November 2023, Boehringer Ingelheim received clearance from the European Commission for SENVELGO— its first oral liquid medication for cats? with diabetes.
- In August 2023, Mars Inc. entered into an agreement to acquire a European Veterinary Reference Laboratory called SYNLAB Vetfrom SYNLAB Group. This complemented its Petcare division’s existing footprint in the full-service veterinary diagnostics business in Europe.??
- In November 2023, Bimeda inaugurated a new manufacturing facility in China for sterile injections and parasite-control products thus extending its capabilities.
- In October 2023, Zoetis commercially launched Librela— its anti-NGF monoclonal antibody treatment in the U.S. for control of canine osteoarthritis pain.
- In August 2023, Boehringer Ingelheim received U.S. FDA clearance for SENVELGO (velagliflozin oral solution) for diabetic cats.
- In June 2023, Mars Inc. acquired a leading provider of advanced veterinary diagnostic solutions— Heska Corp. This expanded the company’s diagnostics lineup.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the animal aids market analysis from 2024 to 2033 to identify the prevailing animal aids market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the animal aids market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global animal aids market trends, key players, market segments, application areas, and market growth strategies.
Key Sources Referred
- Centers for Disease Control and Prevention
- World Organization of Animal Health
- National Center for Biotechnology Information
- The Lancet
- National Perinatal Epidemiology and Statistics Unit (NPESU)
- Science Direct
- Health Resources and Services Administration (HRSA)
- Department of Health and Human Services (HHS)
- National Institutes of Health (NIH)
- AnimalAid.org.UK
Animal Aids Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 1.5 Billion |
 Growth Rate | CAGR of 5.7% |
 Forecast period | 2024 - 2033 |
 Report Pages | 260 |
 By Product Type |
|
 By Animal Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Bayer Animal Health, Dechra Pharmaceuticals plc., CEVA Santé Animale S.A.S., Vetoquinol, Boehringer Ingelheim Animal Health, Phibro Animal Health Corporation., Elanco Animal Health, Zoetis Inc., Merck Animal Health, Virbac |
The growth of the Animal Aids market is driven by increasing pet ownership, rising awareness of animal health and welfare, and advancements in veterinary care and technology. Additionally, the humanization of pets and the willingness of owners to spend more on their animals' well-being contribute significantly to market expansion.
Animal aids refer to tools, devices, and resources designed to assist animals in various ways. These aids can be used to improve the health, mobility, and quality of life of animals, including pets, livestock, and wildlife
The Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health, Bayer Animal Health held a high market position in 2023.
The base year is 2023 in Animal Aids market.
The forecast period for Animal Aids market is 2024 to 2033.
The market value of Animal Aids market in 2033 is $1,523.73 million.
The total market value of Animal Aids market is $870 million in 2023.
Loading Table Of Content...
